According to a new report, published by KBV research, The Global Enteral Syringe Market size is expected to reach $556.9 million by 2031, rising at a market growth of 5.1% CAGR during the forecast period.
Patients with chronic illnesses that affect their digestive or swallowing abilities may need medications that are difficult to administer orally. Enteral syringes allow for the delivery of these medications directly into the gastrointestinal tract, ensuring effective treatment. In paediatric and geriatric populations, where oral medication might be challenging or unsafe, enteral syringes provide a reliable method for administering necessary medications
The Adults segment is registering a CAGR of 4.8 % during the forecast period. Adults, particularly older adults, are more likely to suffer from chronic diseases such as cancer, diabetes, and neurological disorders. These conditions often require enteral feeding to ensure adequate nutrition when oral intake is insufficient or impossible. Chronic conditions often necessitate long-term enteral nutrition support, leading to sustained demand for enteral syringes in the adult population.
The Hospitals segment led the Global Enteral Syringe Market by End User in 2023; thereby, achieving a market value of $342 Million by 2031. Hospitals provide specialized medical care for patients with severe or complex health conditions that often require enteral feeding. Enteral syringes are essential tools for delivering nutrition and medications directly into the stomach or intestines of these patients.
The Disposable segment is growing at a CAGR of 4.8 % during the forecast period. Disposable enteral syringes are designed for single use, eliminating the risk of cross-contamination between patients. This is particularly crucial in healthcare settings where infection control is a top priority.
Full Report: https://www.kbvresearch.com/enteral-syringe-market/
The North America region dominated the Global Enteral Syringe Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $187 Million by 2031. The Europe region is anticipated to grow at a CAGR of 4.9% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 5.6% during (2024 - 2031).
By Age Group
By End User
By Type
Unique Offerings 
